Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of long-term respiratory illness worldwide. It affects millions of people and, left unmanaged, chips away at everyday quality of life. The condition brings persistent breathing difficulty, a chronic cough, and reduced airflow — and while it can't be cured, catching it early usually means its progression can be slowed enough that people keep an active, independent life for years longer.
The trouble is that COPD creeps in. Symptoms build over years, not weeks, so people write off breathlessness on the stairs or a nagging cough as "just getting older" or "just the smoking." By the time it's bad enough to interrupt daily life, a fair amount of lung damage has often already happened and won't reverse.
This is exactly where spirometry testing earns its reputation as the gold standard for diagnosing COPD — it measures lung function objectively, rather than relying on how someone describes their breathing. It can pick up airflow obstruction well before symptoms turn severe, which means treatment can start sooner. According to the NHS's overview of COPD, earlier diagnosis is consistently linked to fewer hospital admissions and better long-term symptom control.
This guide walks through how COPD develops, who's at risk, how spirometry actually works, how to read your results, and what happens once you have a diagnosis.
COPD is a long-term condition that damages the lungs and causes persistent airflow limitation — moving air in and out of the lungs gets harder over time, not easier. It's really an umbrella term covering two conditions that usually show up together.
Chronic bronchitis is inflammation of the airways paired with excess mucus production. The airways narrow, and the result is a persistent cough — often called a "smoker's cough" — plus:
Emphysema damages the tiny air sacs (alveoli) inside the lungs. Normally these expand and contract efficiently with every breath; in emphysema, their walls lose elasticity and stop working properly, which limits how well the lungs exchange oxygen and carbon dioxide. That shows up as:
Most people with COPD have a mix of both conditions, with one usually more dominant than the other. And unlike asthma, the airflow limitation in COPD is largely permanent — medication only partially reverses it, which is exactly why catching it early, before extensive damage sets in, matters so much.
Because COPD develops slowly, the early symptoms are easy to write off as ageing, unfitness, or "just" the effects of smoking. The most common signs include:
As the disease progresses, these symptoms start interfering with things like walking, climbing stairs, or carrying shopping. In more advanced stages, people may also notice breathlessness at rest, unintentional weight loss, swollen ankles or legs, blue-tinged lips or fingertips from low oxygen, or difficulty getting through routine daily tasks.
Most people only look up COPD symptoms once breathing problems have already become a real nuisance. Recognising the condition early changes the long-term outlook, so speak to a healthcare professional if you notice:
A spirometry test can often flag COPD well before any of this becomes severe.
COPD develops after years of exposure to things that damage the lungs and airways — the resulting inflammation narrows the airways and destroys lung tissue over time.
Smoking causes the vast majority of COPD cases. The chemicals in tobacco smoke damage the airways, ramp up mucus production, and gradually destroy the lungs' air sacs. Risk climbs with the number of cigarettes smoked daily, the number of years spent smoking, exposure to second-hand smoke, and cigar or pipe smoking. Even so, not everyone who develops COPD has ever smoked — quitting remains the single biggest lever anyone can pull, and the NHS's stop smoking support is worth a look if you're trying.
Air pollution — outdoor pollution from traffic, industrial pollution, indoor smoke from wood-burning stoves, and biomass fuel exposure — all contribute over the long term. People living in heavily polluted areas carry a higher risk of chronic respiratory disease.
Workplace exposure to dust, chemicals, and fumes damages lungs over years of repeated contact. Construction workers, miners, welders, factory workers, agricultural workers, and textile workers all carry higher risk. The UK's Health and Safety Executive has detailed guidance on occupational lung disease, including how proper respiratory protection cuts exposure in these environments.
Genetics account for a small share of cases. Alpha-1 Antitrypsin Deficiency (AATD) is an inherited condition that leaves people with lower levels of a protein that normally protects the lungs, making emphysema more likely even without a smoking history. The NHS's page on AATD explains when genetic testing might be recommended — usually when COPD shows up at a younger age or there's a strong family history.
Anyone can develop COPD, but certain factors raise the odds substantially. You may be at higher risk if you:
If any of that applies to you, a persistent cough or breathlessness isn't something to shrug off. A spirometry assessment can catch changes in lung function before symptoms get severe.
COPD is progressive — lung function declines over time, and the damage generally doesn't reverse. What early diagnosis does offer is the best shot at slowing that decline and holding onto quality of life longer. Spirometry catches airflow obstruction before symptoms become advanced, which gives people time to make lifestyle changes and start treatment while it still has the most impact.
The benefits of catching it early: faster access to effective treatment, better symptom control, a slower decline in lung function, fewer severe flare-ups, fewer emergency admissions, better exercise tolerance, and a better quality of life overall. For smokers specifically, an early diagnosis often becomes the motivation that finally makes quitting stick — still the single most effective way to slow COPD's progression.
Spirometry is a simple, safe, non-invasive breathing test that measures how well your lungs are working. It's the gold standard for diagnosing COPD because, unlike a chest X-ray or blood test — neither of which can confirm COPD on their own — it directly measures how much air you can breathe out and how fast you can empty your lungs.
Spirometry is used to diagnose COPD, confirm or rule out asthma, assess other chronic lung diseases, measure how severe an obstruction is, track disease progression over time, check whether treatment is working, and assess lung function ahead of certain surgeries. Because COPD builds gradually, spirometry often catches reduced lung function before symptoms turn serious — which means treatment can start while it still preserves the most function.
Your clinician may recommend spirometry if you have symptoms suggestive of COPD, or if you sit in a higher-risk group. That includes anyone who:
Even mild symptoms are worth checking — spirometry can flag airflow obstruction before real damage sets in.
Spirometry measures how much air you can inhale and exhale, and how fast you can breathe out, using a device called a spirometer connected to a disposable mouthpiece. During the test, you'll sit upright, wear a nose clip so air can't escape through your nose, take the deepest breath you can, seal your lips around the mouthpiece, and blow out as hard and fast as possible until your lungs feel completely empty. You'll repeat this a few times to get consistent, reliable readings.
The whole appointment takes around 15 to 30 minutes, including preparation and repeat attempts. Because the result depends on effort, your clinician or respiratory physiologist will coach you through it to get the most accurate reading possible.
A few simple steps help the results come out accurate: avoid smoking for a few hours beforehand, skip a heavy meal right before the test, wear loose clothing that doesn't restrict your breathing, avoid strenuous exercise beforehand, and skip alcohol on the day. If you use inhalers, your clinician may ask you to hold off on certain medications before the test — always follow the specific instructions you're given, since this depends on why the spirometry is being done.
People often expect spirometry to be uncomfortable. It isn't — it's quick and straightforward.
A typical appointment covers a medical assessment (your symptoms, smoking history, existing lung conditions, current medications, past respiratory infections), followed by baseline spirometry, where you perform several breathing manoeuvres into the device — usually at least three acceptable attempts, to make sure the results are consistent.
If airflow obstruction shows up, you may be given an inhaled bronchodilator, then retested 15–20 minutes later. Comparing the before-and-after results — known as post-bronchodilator spirometry — helps distinguish COPD from asthma and shows whether the obstruction is reversible. It's a key part of reaching an accurate diagnosis.
No — it's safe, painless, and non-invasive. Some people feel briefly dizzy, cough, or feel short of breath right after the forceful exhale, but this settles within minutes. It's considered very safe for most people, though it may be postponed after recent chest or eye surgery, a heart attack, a collapsed lung, or if you have severe chest pain or uncontrolled high blood pressure. Your clinician will check whether it's appropriate for you before going ahead.
The question we hear most often is simply: what do these numbers actually mean? Spirometry produces several measurements, but three matter most for a COPD diagnosis — FEV1, FVC, and the FEV1/FVC ratio.
FEV1 (Forced Expiratory Volume in One Second) measures how much air you can forcefully blow out in the first second after a full breath. A lower FEV1 points to narrowed or obstructed airways — the lower it goes, the more lung function has been lost. Your results get compared against predicted values based on your age, height, sex, and ethnicity, to see where you fall relative to what's expected.
FVC (Forced Vital Capacity) measures the total air you can force out after the deepest possible breath — not just the first second, the whole exhale. In COPD, damaged airways tend to collapse during exhalation, trapping air and making it hard to empty the lungs fully.
The FEV1/FVC ratio compares how much of your total breath you can push out in that first second, and it's one of the most important numbers in a COPD diagnosis. In healthy lungs, most of the air comes out quickly. In COPD, narrowed airways slow that down, and the ratio drops. Once bronchodilator treatment has been given, a post-bronchodilator FEV1/FVC below 0.70 (70%) supports a diagnosis of persistent airflow obstruction consistent with COPD. A ratio above that makes COPD less likely, though further assessment might still be needed depending on symptoms and history.
Spirometry gives objective evidence of airflow obstruction, which is what makes it the cornerstone of a COPD diagnosis — symptoms alone can overlap with asthma, heart disease, or other respiratory conditions, but lung function measurements don't lie the same way. Clinicians combine spirometry with your symptoms, medical history, smoking history, physical exam, and any further tests needed.
A COPD diagnosis is generally supported when there are persistent respiratory symptoms, a history of exposure to risk factors like smoking, and a post-bronchodilator FEV1/FVC below 0.70 confirming persistent airflow limitation. The NICE guideline on COPD diagnosis and management (NG115) sets out exactly this combination as the UK clinical standard, which is why spirometry sits at the centre of any proper diagnosis rather than being treated as optional.
It confirms or rules out COPD objectively, catches airflow obstruction before symptoms turn severe, tells COPD apart from asthma and other respiratory diseases, measures how severe the disease is, guides treatment decisions, tracks how the condition changes over time, and shows whether medication is actually working. Without it, an accurate COPD diagnosis is much harder to reach, and the risk of delayed or wrong treatment goes up.
Once spirometry confirms COPD, clinicians grade its severity using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification — based mainly on your post-bronchodilator FEV1 as a percentage of the predicted value for your age, sex, height, and ethnicity.
Same Day Online Booking
No Time Limits Appointments
Online Consultations Available
Latest Blog Posts
NHS GP vs Private GP: Which One Is Right for You?
How to See a Private GP Today: Fast, Flexible Options Explained
Is Private Healthcare Worth It? A Private GP’s Honest Take on Private vs NHS Care
Evening & Weekend Private GP Appointments in London: How to Book Same-Day Care Outside Normal Hours
Private GP Services: A Growing Importance as NHS Plan Appointment Caps
Ready to take the next step?
